James E. Duncan
Papers
1
Total Citations
3
H-Index
1
About
Dr. James E. Duncan is a surgical oncologist whose research focuses on the diagnosis and management of rare gastrointestinal pathologies, particularly histiocytic disorders. His landmark work on Rosai-Dorfman Disease (RDD) of the rectum has fundamentally reshaped understanding of this exceedingly rare condition, which typically presents as cervical lymphadenopathy in young adults. In his most cited 2022 study, Dr. Duncan documented only the 20th known case of gastrointestinal RDD and, critically, identified novel genetic point mutations associated with the disease. This discovery has opened new avenues for targeted therapies in a condition previously managed only through surgical resection. Demonstrating both clinical innovation and technical expertise, Dr. Duncan successfully performed a robotic resection for the rectal RDD case, showcasing the application of minimally invasive techniques to ultra-rare surgical challenges. While his work has garnered 3 citations to date—a significant number given the extreme rarity of the condition—its true impact lies in providing the first genetic framework for understanding GI histiocytic disorders. Dr. Duncan continues to advance the field by bridging molecular pathology with cutting-edge surgical approaches for orphan diseases.
Research Focus
Key Achievements
Top Papers
- 1